Top 3 Performing Pharma and Healthcare Mutual Fund Schemes in Last 5 Years

Prajwal Wakhare
/ Categories: Trending, Mutual Fund
Top 3 Performing Pharma and Healthcare Mutual Fund Schemes in Last 5 Years

Following are the top 3 pharma and healthcare funds in the last 5 years:

Mutual funds focused on the pharma and healthcare sectors have outperformed, delivering an impressive average return of nearly 31 per cent. In the last 5 years, about 9 pharma and healthcare funds have been actively available in the market.

DSIJ’s 'multibagger Pick’ service recommends well researched multibagger stocks with High Returns potential. If this interests you, do download the service details here.

Following are the top 3 pharma and healthcare funds in the last 5 years:

Scheme Name

AUM (Crore) 

TER (per cent)

1 Year Returns

5 Years

Since Launch Returns (per cent)

DSP Healthcare

3,094.08

1.93

53.02

31.82

26.69

ICICI Prudential Pharma Healthcare and Diagnostics PHD Fund

4,987.49

1.92

59.92

31.15

23.83

SBI HEALTHCARE Opportunities

3,346.13

1.95

49.21

29.86

15.82

 

Source: advisorkhoj.com, data as of October 23, 2024.

DSP Healthcare Fund, launched on 05-11-2018, is managed by DSP Mutual Fund. The fund tracks the BSE Healthcare index and has a total asset size of Rs 3,094.08 crore as of 30-09-2024, with a turnover ratio of 6 per cent. It has a TER of 1.93 per cent and charges an exit load of 0.50 per cent if redeemed within 1 month. The fund's NAV as of 22-10-2024 is Rs 40.498. Since inception, the fund has delivered a CAGR of 26.69 per cent, outperforming its benchmark's return of 15.7 per cent.

ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund has an NAV of Rs 37.87 as of 23rd October 2024. The fund's AUM is Rs 4,987.49 crore, with a 1-year CAGR of 58.39 per cent. It carries an exit load of 1.00 per cent and an expense ratio of 1.92 per cent. This equity fund was launched on 12th July 2018, with a minimum investment requirement of Rs 5000 and a minimum SIP of Rs 100.

SBI Healthcare Opportunities Fund previously known as SBI Pharma is an equity sectoral fund focused on pharma and healthcare, launched on 14th July 1999 by SBI Mutual Fund. The fund's asset class is equity, and its benchmark is the BSE Healthcare index. As of 30th September 2024, it has a total asset size of Rs 3,346.13 crore, with a TER of 1.95 per cent. The fund has an exit load of 0.50 per cent if redeemed within 15 days and a turnover rate of 29 per cent. Minimum investments start at ₹5,000, with a top-up option of Rs 1,000. As of 22nd October 2024, the NAV stands at Rs 410.5793. The fund has delivered a CAGR of 15.82 per cent since inception, compared to its benchmark's 15.7 per cent.

Disclaimer: The article is for informational purposes only and not investment advice.

Rate this article:
5.0

Leave a comment

Add comment

DSIJ MINDSHARE

Mkt Commentary31-Oct, 2024

Mindshare31-Oct, 2024

Mindshare31-Oct, 2024

Mkt Commentary31-Oct, 2024

Mindshare31-Oct, 2024

Knowledge

MF28-Oct, 2024

Personal Finance28-Oct, 2024

Technical23-Oct, 2024

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR